Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Similar documents
ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Managing the Low Output Low Gradient Aortic Stenosis Patient

Low Gradient Severe? AS

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Aortic Valvular Stenosis

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

Low Gradient AS: Multi-Imaging Modalities

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Aortic Valve Replacement Improves Outcome in Patients with Preserved Ejection Fraction: PRO!

Sténose aortique à Bas Débit et Bas Gradient

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Exercise Testing/Echocardiography in Asymptomatic AS

Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies


Workshop Facing the challenge of TAVI 2016

Spotlight on Valvular Heart Disease Guidelines

Aortic stenosis aetiology: morphology of calcific AS,

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

The best in heart valve disease Aortic valve stenosis

Natural History and Echo Evaluation of Aortic Stenosis

Indicator Mild Moderate Severe

Comprehensive Echo Assessment of Aortic Stenosis

March yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months

Choose the grading of diastolic function in 82 yo woman

CASES IN ADVANCED IMAGING

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Usually we DON T need to go beyond the gradient

Valvular Heart Disease: Assessment and Timing of Intervention. Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Michigan Society of Echocardiography 30 th Year Jubilee

Blank DISCLOSURES 1/17/2017 COMPLEX VALVE CASES CHALLENGES IN EVALUATING AND MANAGING MULTIVALVULAR HEART DISEASE ECHO HAWAII 1/23/17 NONE

Exercise PHT in valvular heart disease. Julien Magne CHU Limoges, France

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Echocardiographic evaluation of mitral stenosis

Aortic Stenosis Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Diastolic Heart Function: Applying the New Guidelines Case Studies

Imaging and heart failure

Valvular Guidelines: The Past, the Present, the Future

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;

ESC / EACTS new valvular guidelines- Update

Aortic stenosis with concomitant mitral regurgitation

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Nothing to Disclose. Questions. Disclosure Asymptomatic Severe Aortic Stenosis: (When) Should One Intervene? Paul Wood at the Nathanson Lecture, 1958

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

The difficult patient with mitral regurgitation

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Cases in Stress Echo DISCLOSURE

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Imaging in dilated cardiomyopathy : factors associated with a poor outcome

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Diastolic Function Assessment New Guideline Update Practical Approach

Strain Imaging: Myocardial Mechanics Simplified and Applied

Clinical Outcome in Patients with Aortic Stenosis

History of Stress Testing. Disclosure. Overview. Stress Echocardiography New Applications. and Comparison with Other Stress.

New Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego

Low gradient severe aortic stenosis with preserved left ventricular ejection fraction

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes

Steven J. Lester MD, FRCP(C), FACC, FASE Relevant Financial Relationship(s) None Off Label Usage None

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Constriction vs Restriction Case-based Discussion

Potential conflicts of interest

Prosthetic valve dysfunction: stenosis or regurgitation

Echo evaluation for TAVR. From the General Cardiologist to the Interventional Echocardiologist

Asymptomatic Valvular Disease:

Stress Echocardiography in VHD: is myocardial contrac8on a reliable marker for ischemia?

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Severe aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

Cardiac Care Network of Ontario

The correlation of AVA measured by transthoracic, transesophageal echocardiography and cardiac CT

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong

Aortic Stenosis.

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Stress Testing in Valvular Disease

What echo measurements are key prior to MitraClip?

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Diastolic Function Assessment Practical Ways to Incorporate into Every Echo

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Quantification of Mitral Stenosis: Planimetry, pressure Half time, Continuity Common Errors

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Cardiac Perioperative Risk Assessment American Heart Association Guidelines

2017 ESC/EACTS Guidelines for the management of valvular heart disease

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology

Aortic Stenosis: LVOT Obstruction

Transcription:

Role of Stress Echo in Valvular Heart Disease Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Exercise echocardiography Dobutamine echocardiography

Usefulness of exercise echo in VHD (Lancellotti P, EHJ CVI 2016;17:1191) 76 yo male At 33 yo, abnormal ECG pointed At 63 yo, exertional dyspnea occurred Diagnosed as idiopathic DCM by cath and myocardial biopsy and B-blocker started Repeated admissions due to HF symptoms EF 19%, +1-2 Mr, +1Tr, TRPG 16 mmhg What is the cause of HF symptoms?

pre 15W 30W 45W dyspnea SPAP 15 mmhg 35 mmhg 40 mmhg 66 mmhg BP 100/56 116/68 128/70 154/76 HR 67 85 93 110 Ex-induced PH and increase in MR may be causes of HF symptoms. Indications of intervention for MR Appearance of symptoms in asymptomatic patient Primary MR Poor prognosticators Dynamic PH (SPAP Limited CR (<5% increase in EF, <2% increase in GLS) Limited RVCR (TAPSE <19 mm) Secondary MR Increase in MR (increase in ERO 2 ) Dynamic

Indications of intervention for MS Exercise stress echo mpg >15 mmhg on exertion SPAP >60 mmhg on exertion Dobutamine stress echo (if the patient cannot exercise) mpg >18 mmhg 62 yo female At 58 yo, diastolic heart murmur pointed Diagnosed as MS (MVA = 1.6 cm 2 ) At 60 yo, exertional dyspnea occurred MVA = 1.6 cm 2 (planimetry), 1.4 cm 2 (PHT), 1.3 1.5 cm 2 (continuity equation) mpg = 6 7 mmhg TRPG = 19 mmhg

Echo at rest pre 25W 50W 75W mpg 6 mmhg 13 mmhg 21 mmhg 20 mmhg TRPG 24 mmhg 53 mmhg 59 mmhg 60 mmhg Surgery was recommended.

Indications of intervention for AR Appearance of symptoms in asymptomatic patient Limited CR (<5% increase in EF) ) Dynamic MR However, there is limited evidence. Indications of stress echo in AS Asymptomatic severe AS Low-flow, low-gradient AS With reduced EF (classical LFLG AS) Pseudo-severe AS True-severe AS With preserved EF (paradoxical AS)

Indications of intervention for asymptomatic severe AS Appearance of symptoms Ex-induced hypotension Increase in mpg -20 mmhg) Limited CR (<1.4% increase in GLS*) Induced PH (SPAP >60 mmhg) (*, Donal E, EHJ CVI 2011;12:235) Low-flow, low-gradient AS AVA <1.0 cm 2, mpg <40 mmhg, LVEF <50% True severe AS Severe AS Low SV due to LV systolic dysfunction low PG Pseudo severe AS Moderate AS Low SV due to LV systolic dysfunction cannot open AV small AVA and low PG Paradoxical low-flow, low-gradient AS EF >50% but low SV (SVi <35 ml/m 2 ) DSE

Dobutamine stress echo in AS Start from 5 /kg/min Increase DOB by 5 /kg/min every 5 min until 20 /kg/min % increase in SV 20% contractile reserve (+) mpg 2 severe AS mpg < 2 moderate AS % increase in SV <20% contractile reserve (-) Severe calcification severe AS Mild calcification moderate AS CT score is helpful. CT score>1650 u, JACC2012;60:1845 71 yo male Prior MI, chronic HF, post CRT-D implantation LVEDD = 72 mm, LVESD = 66 mm, EF = 25% AVA = 0.68 cm 2, mpg = 28 mmhg, SVi = 29 ml/m 2 Mild MR, mild AR Pseudo-severe AS or true-severe AS?

Echo at rest Dobutamine stress echo Pre 5 g/kg/min 10 g/kg/min 20 g/kg/min SV (ml) 45 58 60 63 ET (ms) 0.30 0.29 0.30 0.26 Flow rate (ml/s) 150 202 199 242 mpg (mmhg) 23 21 28 35 AVA (cm2) 0.71 0.95 0.94 0.94 SV = (63 45) / 45 = 40% >20% Flow reserve (+) AVA at peak DSE = 0.94 <1.0 cm 2 True-severe AS TAVI was performed.

After TAVI AVA: from 0.68 to 1.17 cm 2 LVEDD: from 72 to 65 mm, LVESD: from 66 to 57 mm, EF: from 25 to 31% NYHA class: from III to I 70 yo female (A case when I was young ) History of present illness Exertional dyspnea starting 9 yrs ago. Diagnosed as HHD at 8 yrs ago by cath and biopsy. Repeated admission due to CHF. Had nocturnal dyspnea recently. Past medical history Hypertension since 50 y/o, DM, hyperlipidemia PCI to mid LAD in 5 yrs ago with residual stenosis at Dx br ECG Atrial fibrillation with wide QRS complex (CLBBB)

70 yo female with LV dysfunction EF = 17% AV PG = 30 mmhg AVA = 0.73 cm 2 Low dose DSE Rest 5 g/kg/min 10 g/kg/min 20 g/kg/min HR 84 85 118 132 BP 102/54 95/66 101/55 90/49 AVA (cm 2 ) 0.71 0.71 0.90 0.73 Peak PG (mmhg) 25 25 34 36 TVI (cm) 50 47 54 44 TVI x HR 4200 3995 6372 5808 No LV flow reserve!

Intraoperative finding No calcification, pliable cusps! TTE TEE is important. If no CR, you cannot determine the severity. Look at the valve closely or use CT. Assess the grade of calcification and pliability of cusps.

Limited CR (flow reserve) Limited CR is due to: Afterload mismatch Associated CAD Myocardial damage due to prior MI or myocardial fibrosis Limited CR is seen in 1/3 of patients and is associated with high operative mortality (6 33%) with AVR. However, limited CR does not predict absence of LV function improvement after AVR. Projected AVA (AVA at flow rate of 250 ml/s) should be calculated to differentiate pseudo-severe AS and true-severe AVA proj = Projected AVA AVA Q x (250 Q rest ) + AVA rest (Q = SV / LVET) AVA proj = AVA at normal flow rate (250 ml/s), AVA rest = AVA at rest, AVA = absolute changes in AVA during DSE, Q rest = mean transvalvular flow rate at rest, Q = absolute changes in mean transvalvular flow rate during DSE. Projected AVA AVA proj = 1.02 cm 2 AVA (cm 2 ) Concerns: Slope determination from only 4 points. Accuracy of Q (esp. ET) Are you confident with this measurement? (Blais C, Circulation 2006;113:711)

Simplified projected AVA AVA proj = AVA peak AVA rest Q peak -Q rest x (250 Q rest ) + AVA rest (Q = SV / LVET) AVA proj = AVA at normal flow rate (250 ml/s), AVA rest = AVA at rest, AVA peak = AVA at peak, Q rest = mean transvalvular flow rate at rest, Q peak = mean transvalvular flow rate at peak Calculation of projected AVA and simplified projected AVA should be carefully performed. Concerns: Slope determination from only 2 points. Accuracy of Q (esp. ET) (Clavel MA, JASE 2010;23:380)

Indications of stress echo in VHD Identify patients in need of intervention Severe VHD without symptoms Truly asymptomatic or not? Non-severe VHD with symptoms Stress echo Hemodynamic disturbances or not? (Ex-induced hypotension, arrhythmia, PH) Intervention VHD with low flow Truly severe or not?